Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
Most recent articles by Alison Kanski
Five things for pharma marketers to know: Monday, September 28, 2020
Novavax began late-stage trial of COVID-19 vaccine; Pharmacies prepare for increased flu shot demand; The inaugural MM+M 40 Under 40 event is September 29.
Rona Fairhead, former Financial Times CEO and BBC Chair, joins SurvivorNet board
The goal for SurvivorNet going forward is to develop new products and content for cancer patients and doctors, Fairhead said.
The Escalator: FCB Health Network names Sommer Bazuro first chief medical officer
Plus people moves at Omnicom and Astellas.
Five things for pharma marketers to know: Thursday, September 24, 2020
U.S. health officials testify before Congress; J&J begins late-stage vaccine trial; AstraZeneca’s COVID-19 vaccine trial remains under investigation by FDA.
Doctors find safe spaces to discuss mental health in FCB Health initiative, Disappearing Doctors
FCB has partnered with Sermo, Haymarket Media Group and the National Suicide Prevention Lifeline.
FDA cracks down on e-cigarette makers that didn’t submit marketing applications
The agency sent warning letters to vape companies selling e-cigarettes without premarket authorization.
Five things for pharma marketers to know: Wednesday, September 23, 2020
FDA to issue guidance outlining tougher standards for a COVID-19 vaccine; Biden campaign balances criticizing Trump’s vaccine efforts with encouraging trust in vaccines; U.S. surpasses 200,000 deaths from coronavirus.
Five things for pharma marketers to know: Tuesday, September 22, 2020
CDC reverses stance on airborne transmission of COVID-19; Group of Black doctors to independently vet COVID-19 decisions; Join the virtual MM+M Hall of Femme today.
Campaign: Blood Equality effort expands to include COVID-19 antibody donation
The Blood Equality campaign, created by GMHC and FCB Health New York, advocates to reverse the ban on gay and bisexual men donating blood.
